{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:23:32Z","timestamp":1790771012407,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcin.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T03:26:54Z","timestamp":1730172414000},"page":"2325-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antithrombotic Therapy in High Bleeding Risk, Part II"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3909-182X","authenticated-orcid":false,"given":"Mattia","family":"Galli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-278X","authenticated-orcid":false,"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Berteotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-6742","authenticated-orcid":false,"given":"Giuseppe","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-6430","authenticated-orcid":false,"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-3968","authenticated-orcid":false,"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-574X","authenticated-orcid":false,"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jcin.2019.08.006","article-title":"Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease","volume":"12","author":"Cho","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ehjcvp\/pvz036","volume":"6","author":"Savarese","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"19","key":"10.1016\/j.jcin.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jcin.2024.08.022","article-title":"Antithrombotic therapy in high bleeding risk part I: percutaneous cardiac interventions","volume":"17","author":"Galli","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873211012121","article-title":"European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis","volume":"6","author":"Bonati","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jcin.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jcin.2024.03.015","article-title":"Randomized trial comparing a stent-avoiding with a stent-preferred strategy in complex femoropopliteal lesions","volume":"17","author":"Wittig","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2022.10.023","article-title":"Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: a network meta-analysis","volume":"370","author":"Galli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","volume":"42","author":"Aboyans","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejvs.2023.12.001","article-title":"External validation of the OAC3-PAD bleeding score in a nationwide population of patients undergoing invasive treatment for peripheral arterial disease","volume":"67","author":"\u00d8rskov","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-021-00598-1","article-title":"Bleeding avoidance strategies in percutaneous coronary intervention","volume":"19","author":"Capodanno","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2022.10.023","article-title":"Timing, selection, modulation, and duration of P2Y(12) inhibitors for patients with acute coronary syndromes undergoing PCI","volume":"16","author":"Capodanno","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008069","article-title":"Impact of procedural bleeding in peripheral artery disease","volume":"12","author":"Kansal","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1538-7836.2011.04437.x","article-title":"Differential propensity for major hemorrhagic events in patients with different types of arterial disease","volume":"9","author":"Achterberg","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jcin.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejvs.2021.12.019","article-title":"The OAC(3)-PAD risk score predicts major bleeding events one year after hospitalisation for peripheral artery disease","volume":"63","author":"Behrendt","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"10.1016\/j.jcin.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.31083\/j.rcm2308286","article-title":"Bleeding complications in patients undergoing percutaneous coronary intervention","volume":"3","author":"Galli","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.4244\/EIJ-D-21-00181","article-title":"Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition","volume":"17","author":"Gragnano","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00380-021-01804-3","article-title":"Bleeding events and mid-term mortality in the patients undergoing endovascular interventions for peripheral artery disease of the lower limbs based on the academic research consortium high bleeding risk criteria","volume":"36","author":"Yoshioka","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jcin.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.4244\/EIJ-D-22-00475","article-title":"Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions","volume":"18","author":"Tomoi","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2024.09.011_bib25","article-title":"Clinical outcomes based on high bleeding risk in patients with lower extremity peripheral artery disease who have undergone endovascular therapy","author":"Yoshioka","year":"2023","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1526602819866191","article-title":"A\u00a0new preprocedural score to predict bleeding complications of endovascular interventions for peripheral artery disease","volume":"26","author":"Spiliopoulos","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejvs.2023.04.026","article-title":"Nationwide study in France to predict one year major bleeding and validate the OAC3-PAD score in patients undergoing revascularisation for lower extremity arterial disease","volume":"66","author":"Lareyre","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.09.011_bib31","first-page":"3515","article-title":"Short-term clinical outcomes of single versus dual antiplatelet therapy after infrainguinal endovascular treatment for peripheral arterial disease","volume":"9","author":"Ipema","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib33","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2024.09.011_bib35","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17512433.2023.2154651","article-title":"Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications","volume":"16","author":"Galli","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jcin.2024.09.011_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ehjcvp\/pvac022","article-title":"Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs dual antiplatelet therapy","volume":"8","author":"Galli","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jcin.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1055\/a-1730-8725","article-title":"Pharmacodynamic profiles of dual-pathway inhibition with or without clopidogrel versus dual antiplatelet therapy in patients with atherosclerotic disease","volume":"122","author":"Galli","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcin.2024.09.011_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ehjcvp\/pvab043","article-title":"Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials","volume":"8","author":"Galli","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jcin.2024.09.011_bib42","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.121.054835","article-title":"Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: insights from the VOYAGER PAD trial","volume":"144","author":"Debus","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.09.011_bib43","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.09.011_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejvs.2021.05.028","article-title":"Editor's Choice - external applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: the COPART registry","volume":"62","author":"Lap\u00e9bie","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib45","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40265-022-01756-6","article-title":"Antithrombotic therapy for symptomatic peripheral arterial disease: a systematic review and network meta-analysis","volume":"82","author":"Willems","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jcin.2024.09.011_bib46","article-title":"International consensus statement on platelet function and genetic testing for guiding oral P2Y12 inhibitor treatment in percutaneous coronary intervention: 2024 update","author":"Angiolillo","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2024.09.011_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2021.12.007","article-title":"Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention","volume":"33","author":"Galli","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib48","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(21)00533-X","article-title":"Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"397","author":"Galli","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2024.09.011_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/eurheartj\/ehab836","article-title":"Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials","volume":"43","author":"Galli","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.09.011_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jvs.2023.12.028","article-title":"Platelet function testing and clinical outcomes in peripheral arterial disease: Systematic review and narrative synthesis","volume":"80","author":"Kankaria","year":"2024","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib51","article-title":"Optimizing platelet inhibition in peripheral artery disease: a comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography","author":"Lee","year":"2024","journal-title":"Vascular"},{"key":"10.1016\/j.jcin.2024.09.011_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jvs.2022.08.015","article-title":"Variability of antiplatelet response in patients with peripheral artery disease","volume":"77","author":"Majumdar","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2024.06.041","article-title":"The use of clot strength as a predictor of thrombosis in peripheral artery disease","volume":"109","author":"Suarez Ferreira","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1024\/0301-1526\/a000998","article-title":"Management of chronic peripheral artery disease patients with indication for endovascular revascularization","volume":"51","author":"Heiss","year":"2022","journal-title":"Vasa"},{"key":"10.1016\/j.jcin.2024.09.011_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1538574416665986","article-title":"Acute carotid stent thrombosis: a comprehensive review","volume":"50","author":"Moulakakis","year":"2016","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00006123-200008000-00013","article-title":"Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries","volume":"47","author":"Meyers","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jcin.2024.09.011_bib57","first-page":"1130","article-title":"Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients","volume":"107","author":"Ogasawara","year":"2007","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jcin.2024.09.011_bib58","article-title":"Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion","volume":"64","author":"Yoshimura","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jcin.2024.09.011_bib59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2024.09.011_bib60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ehjcvp\/pvad063","article-title":"External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis","volume":"9","author":"Munaf\u00f2","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jcin.2024.09.011_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00270-023-03419-9","article-title":"Prediction of bleeding by the PRECISE-DAPT score in patients with carotid artery stenting","volume":"46","author":"Ramazanoglu","year":"2023","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor's Choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Naylor","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib63","doi-asserted-by":"crossref","first-page":"26s","DOI":"10.1016\/j.jvs.2021.04.074","article-title":"The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00270-005-5288-y","article-title":"Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting","volume":"29","author":"Dalainas","year":"2006","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib65","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejvs.2005.01.012","article-title":"The benefits of combined anti-platelet treatment in carotid artery stenting","volume":"29","author":"McKevitt","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/neurintsurg-2020-016008","article-title":"Dual antiplatelet therapy after carotid artery stenting: trends and outcomes in a large national database","volume":"13","author":"Sussman","year":"2021","journal-title":"J\u00a0Neurointerv Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib67","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.4244\/EIJV12I5A109","article-title":"Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: clinical results of a multidisciplinary approach","volume":"12","author":"Nerla","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2024.09.011_bib68","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3174\/ajnr.A7482","article-title":"Antithrombotic treatment after carotid stenting in patients with concomitant atrial fibrillation","volume":"43","author":"Pardo-Galiana","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jcin.2024.09.011_bib69","first-page":"5242","article-title":"Carotid artery stenting in patients with atrial fibrillation: direct oral anticoagulants, brief double antiplatelets, and testing strategy","volume":"10","author":"Cohen","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib70","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41598-022-05546-8","article-title":"Choice of antithrombotic therapy for patients with atrial fibrillation undergoing carotid angioplasty and stenting: a nationwide population-based study","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcin.2024.09.011_bib71","first-page":"164","article-title":"Antithrombotic therapy in peripheral artery disease: current evidence and future directions","volume":"10","author":"Canonico","year":"2023","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jcin.2024.09.011_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ehjcvp\/pvv053","article-title":"Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions","volume":"2","author":"Widimsk\u00fd","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jcin.2024.09.011_bib73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/SLA.0000000000000612","article-title":"Results and factors affecting early outcome of fenestrated and\/or branched stent grafts for aortic aneurysms: a multicenter prospective study","volume":"261","author":"Marzelle","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib75","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ejvs.2022.03.002","article-title":"Editor's Choice - PRINciples of optimal antithrombotiC therapy and coagulation managEment during elective fenestrated and branched EndovaScular aortic repairS (PRINCE(2)SS): an international expert based Delphi consensus study","volume":"63","author":"D'Oria","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib76","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejvs.2016.05.013","article-title":"The Endovascular sealing device in combination with parallel grafts for treatment of juxta\/suprarenal abdominal aortic aneurysms: short-term results of a novel alternative","volume":"52","author":"De Bruin","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2024.09.011_bib77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/2050640620916681","volume":"8","author":"Terlouw","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jcin.2024.09.011_bib78","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2024.09.011_bib79","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1358863X18821816","article-title":"First International Consensus on the diagnosis and management of fibromuscular dysplasia","volume":"24","author":"Gornik","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.jcin.2024.09.011_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5152\/dir.2017.16415","article-title":"Percutaneous renal artery revascularization after prolonged ischemia secondary to blunt trauma: pooled cohort analysis","volume":"23","author":"Jahangiri","year":"2017","journal-title":"Diagn Interv Radiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824011944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824011944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:18:22Z","timestamp":1761715102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824011944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":80,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1936879824011944"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2024.09.011","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in High Bleeding Risk, Part II","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}